Because of a lapse in government funding, the information on this website may not be up to date transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at USA.gov.

NCI Dictionary of Cancer Terms

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

The NCI Dictionary of Cancer Terms features 8,214 terms related to cancer and medicine.

We offer a widget that you can add to your website to let users look up cancer-related terms. Get NCI’s Dictionary of Cancer Terms Widget.

Browse:
sunitinib
(soo-NIH-tih-nib)
A drug used to treat advanced renal cell carcinoma (a type of kidney cancer). It is also used as adjuvant therapy to treat renal cell carcinoma in patients who had surgery to remove the kidney and have a high risk that the cancer will come back. Sunitinib is also used to treat certain types of pancreatic cancer and gastrointestinal stromal tumors (GIST) in some patients. It is also being studied in the treatment of other types of cancer. Sunitinib blocks certain proteins, which may help keep cancer cells from growing. It may also prevent the growth of new blood vessels that tumors need to grow. Sunitinib is a type of tyrosine kinase inhibitor and a type of angiogenesis inhibitor. Also called SU011248, SU11248, sunitinib malate, and Sutent.